| 200 | 3 | 87 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨国产与进口碘克沙醇在心血管高危人群冠脉造影和介入治疗中的效果和安全性。方法:将2014年1月至2015年12月广东省第二人民医院收治的226例心血管高危人群作为研究对象,随机分为国产组(国产碘克沙醇)和进口组(进口碘克沙醇),每组各113例,观察两组患者的造影效果、手术前后肾功能变化情况。结果:国产组和进口组患者不良反应发生率、造影总有效率分别为3.54%和2.85%、97.34%和98.23%,两组比较,差异均无统计学意义(均P>0.05);国产组患者血尿素氮(BUN)、血肌酐(Scr)、血尿素等肾功能指标治疗前后差异无统计学意义(P>0.05)。结论:国产碘克沙醇注射液在冠脉造影和介入治疗高危心血管人群的过程中造影效果优良、安全性比较高,且价位低廉,可在临床范围内推广使用。
Abstract:Objective: To explore the efficacy and safety of domestic vs imported iodixanol in coronary angiography and interventional therapy among high-risk individuals for cardiovascular diseases. Methods:Included in this study were 226 high-risk individuals for cardiovascular diseases treated at the Second People' s Hospital of Guangdong Province between January 2014 and December 2015. The subjects were randomly divided into domestic agent group( using domestic iodixanol) and imported agent group( using imported iodixanol),with113 subjects in each group. The two groups were compared for contrasted imaging and changes in renal function before and after procedure. Results: The rates adverse reactions and total efficiency of angiography 3. 54% vs2. 85%,and 97. 34% vs 98. 23%,in the domestic agent group vs imported agent group respectively,with no statistically significant difference between the groups( P > 0. 05). After the procedure,patients in the domestic agent group did not show any statistically significant change in renal function parameters( including BUN,Scr and blood urea) from baseline( P > 0. 05). Conclusion: Domestic iodixanol injection is with satisfactory imaging efficiency,good safety and lower medical cost in coronary angiography and interventional therapy among high-risk individuals for cardiovascular diseases,and therefore is justified for widespread use in clinical practice.
[1]熊龙根,陆东凤,刘世明,等.直接经皮冠状动脉介入治疗80岁以上急性心肌梗死患者的临床评价[J].中华生物医学工程杂志,2009,15(5):398-401.
[2]刘振良,高全清,贾国渠,等.国产碘克沙醇在心血管高危人群冠脉造影和介入治疗的安全性观察[J].介入放射学杂志,2015,24(2):106-109.
[3]李慧,杨守忠.心电图墓碑样改变患者冠脉造影情况及介入治疗的疗效观察[J].中外健康文摘,2013,19(17):689-693.
[4]Wang C,Huang Q,Liu J,et al.Safety and efficacy of domestic iodixanol injection in interventional neuroradiology:a multicenter clinical trial[J].Chi J Cerebrovasc Dis,2015,13(4):368-370.
[5]余海佳,楚英杰.肾功能不全患者冠脉介入应用碘克沙醇和碘普罗胺术后发生对比剂肾病的Meta分析[J].中国实用医刊,2014,41(7):4-6.
[6]Han SK,Park SC,Lee SH,et al.Emergency coronary angiography in out-of-hospital cardiac arrest patients without STEMI[J].Am J Emerg Med,2016,34(1):118.e1-118.e3.
[7]Dong-Ho S,Dong-Ju C,Tae-Jin Y,et al.Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography[J].Am J Cardiol,2011,108(2):189-194.
[8]Oh MS,Kwon JE,Kim KJ,et al.Subarachnoid hemorrhage mimicking leakage of contrast media after coronary angiography[J].Korean Circ J,2012,42(3):197-200.
[9]Ozbulbul NI,Yurdakul M,Tola M.Comparison of a lowosmolar contrast medium,iopamidol,and an iso-osmolar contrast medium,iodixanol,in MDCT coronary angiography[J].Coron Artery Dis,2010,21(7):414-419.
[10]黄程.不同类型对比剂对75岁以上老年人行冠脉介入术后肾功能的影响[D].福州:福建医科大学,2014.
[11]芮浩淼,齐超,吴长燕,等.冠脉造影SYNTAX积分对老年冠心病患者经皮冠状动脉介入治疗预后的预测作用[J].中国老年学杂志,2014,34(1):85-86.
[12]王朝霞.宝石CT心脏冠脉血管成像中不同浓度造影剂注射剂量和注射速度的研究[D].太原:山西医科大学,2014.
[13]Mccullough PA,Bmwn JR.Effbcts of Intra-Arterial and intravenous Iso.Osmolar contrast medium odjxanoll on the risk of Contrast-Induced acute kidney injury:a MetaAnalysis[J].Cardiorenal Med,2011,1(4):220-234.
基本信息:
中图分类号:R541.4
引用信息:
[1]刘君,聂大奥,靳文.国内外碘克沙醇在心血管高危人群冠脉造影和介入治疗的有效性和安全性比较[J].广州医科大学学报,2016,44(03):45-47.
基金信息:
广东省医学科研基金(A2015293)